COVID-19 Patients with Pulmonary Fibrotic Tissue: Clinical Pharmacological Rational of Antifibrotic Therapy
Antonio Vitiello, Chiara Pelliccia, Francesco Ferrara
Topics & Concepts
MedicinePulmonary fibrosisPandemicOutbreakARDSIntensive care medicineLungDiseaseCoronavirusFibrosisEpidemiologyImmunologyCoronavirus disease 2019 (COVID-19)Internal medicinePathologyInfectious disease (medical specialty)Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisLong-Term Effects of COVID-19COVID-19 Clinical Research Studies